4//SEC Filing
Palaniappan Jyoti 4
Accession 0001209191-21-022205
CIK 0001478320other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:00 PM ET
Size
13.2 KB
Accession
0001209191-21-022205
Insider Transaction Report
Form 4
Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-18−16,052→ 108,948 totalExercise: $22.55Exp: 2030-03-19→ Common Stock (16,052 underlying) - Exercise/Conversion
Common Stock
2021-03-18$22.55/sh+16,052$361,973→ 25,210 total - Sale
Common Stock
2021-03-18$43.04/sh−8,342$359,040→ 16,868 total - Sale
Common Stock
2021-03-18$43.83/sh−5,971$261,709→ 10,897 total - Sale
Common Stock
2021-03-18$45.32/sh−1,739$78,811→ 9,158 total
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $42.60 to 43.51, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $43.63 to 44.53, inclusive.
- [F4]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $44.63 to 45.54, inclusive.
- [F5]The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001807021
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 9:00 PM ET
- Size
- 13.2 KB